TRIM35 Antibodies

Santa Cruz Biotechnology offers a broad range of TRIM35 monoclonal antibodies for investigating TRIM35 in various biological processes. TRIM35 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRIM35, a member of the tripartite motif (TRIM) protein family, plays a crucial role in regulating immune responses and cellular signaling pathways. Research has shown TRIM35's involvement in inflammation modulation and its potential connections to various diseases, including cancer and autoimmune disorders. Understanding TRIM35 function is essential for elucidating its contributions to cellular homeostasis and disease mechanisms. Researchers worldwide rely on TRIM35 monoclonal antibodies to advance their studies in protein-protein interactions and cellular pathways. Current investigations focus on TRIM35's role in immune system regulation and its potential as a therapeutic target. Ongoing research continues to uncover new functions and mechanisms of TRIM35 in health and disease. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful discoveries that contribute to the advancement of scientific knowledge and therapeutic development.